CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

HOUSTON, TX / ACCESSWIRE / September 4, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and …
Jetzt den vollständigen Artikel lesen